| CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cells C Haist, E Schulte, N Bartels, A Bister, Z Poschinski, TC Ibach, K Geipel, ... Oral Oncology 116, 105259, 2021 | 36 | 2021 |
| Epigenetic priming of bladder cancer cells with decitabine increases cytotoxicity of human EGFR and CD44v6 CAR engineered T-cells CM Grunewald, C Haist, C König, P Petzsch, A Bister, E Nößner, C Wiek, ... Frontiers in Immunology 12, 782448, 2021 | 26 | 2021 |
| Genetic engineering and enrichment of human NK cells for CAR-enhanced immunotherapy of hematological malignancies M Soldierer, A Bister, C Haist, A Thivakaran, SC Cengiz, S Sendker, ... Frontiers in Immunology 13, 847008, 2022 | 23 | 2022 |
| Advances and challenges in cell biology for cultured meat B Martins, A Bister, RGJ Dohmen, MA Gouveia, R Hueber, L Melzener, ... Annual review of animal biosciences 12 (1), 345-368, 2024 | 20 | 2024 |
| A novel CD34-derived hinge for rapid and efficient detection and enrichment of CAR T cells A Bister, T Ibach, C Haist, D Smorra, K Roellecke, M Wagenmann, ... Molecular Therapy-Oncolytics 23, 534-546, 2021 | 14 | 2021 |
| Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas C Haist, Z Poschinski, A Bister, MJ Hoffmann, CM Grunewald, ... Oral Oncology 129, 105867, 2022 | 11 | 2022 |
| Optimized NGFR-derived hinges for rapid and efficient enrichment and detection of CAR T cells in vitro and in vivo A Bister, T Ibach, C Haist, G Gerhorst, D Smorra, M Soldierer, K Roellecke, ... Molecular Therapy-Oncolytics 26, 120-134, 2022 | 9 | 2022 |
| Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome level MA Skowron, K Eul, A Stephan, GF Ludwig, GA Wakileh, A Bister, ... Molecular Oncology 16 (17), 3107-3127, 2022 | 8 | 2022 |
| Synergistic interaction of the class IIa HDAC inhibitor CHDI0039 with bortezomib in head and neck cancer cells C Schrenk, LM Bollmann, C Haist, A Bister, C Wiek, M Wecker, D Roth, ... International Journal of Molecular Sciences 24 (6), 5553, 2023 | 4 | 2023 |
| Advanced multiparametric image spectroscopy and super-resolution microscopy reveal a minimal model of CD95 signal initiation N Bartels, NTM van der Voort, O Opanasyuk, S Felekyan, A Greife, ... Science Advances 10 (35), eadn3238, 2024 | 2 | 2024 |
| A Minimal Model of CD95 Signal Initiation Revealed by Advanced Super-resolution and Multiparametric Fluorescence Microscopy N Bartels, NTM van der Voort, A Greife, A Bister, C Wiek, CAM Seidel, ... bioRxiv, 2022.11. 29.518370, 2022 | 2 | 2022 |
| A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma T Ryl, E Afanasyeva, T Hartmann, M Schwermer, M Schneider, ... Communications Biology 7 (1), 919, 2024 | | 2024 |
| Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma T Ryl, E Afanasyeva, T Hartmann, M Schwermer, M Schneider, ... Communications Biology 7, 2024 | | 2024 |
| Kombination aus CAR-T-Zelltherapie und BITEs als optimierte Behandlungsstrategie für Kopf-Hals-Karzinome (HNSCC) K Scheckenbach, PF Steffan, C Haist, S Hüsken, A Bister, M Wagenmann, ... Laryngo-Rhino-Otologie 102 (S 02), 2023 | | 2023 |
| Combination of CAR-T cell therapy and BITEs as an optimized treatment strategy for head and neck cancer (HNSCC) K Scheckenbach, FP Steffan, C Haist, S Hüsken, A Bister, M Wagenmann, ... Laryngo-Rhino-Otologie 102 (S 02), 2023 | | 2023 |
| Genetic engineering of human NK-cells for CAREnhanced immunotherapy of haematological malignancies M Soldierer, A Bister, C Haist, A Thivakaran, SC Cengiz, D Smorra, ... HUMAN GENE THERAPY 33 (23-24), A122-A122, 2022 | | 2022 |
| A universally usable, CD34-derived, hinge domain for the treatment of head and neck cancer as well as solid and hematological cancers using CAR T-cell therapy K Scheckenbach, C Haist, T Ibach, D Smorra, K Roellecke, N Gattermann, ... Laryngo-Rhino-Otologie 101 (S 02), 2022 | | 2022 |
| Eine universal nutzbare, von CD34-abgeleitete, Hinge-Domäne für die Behandlung von Kopf-Hals-Karzinomen sowie soliden und hämatologischen Erkrankungen mittels CAR T-Zelltherapie K Scheckenbach, C Haist, T Ibach, D Smorra, K Roellecke, N Gattermann, ... Laryngo-Rhino-Otologie 101 (S 02), 2022 | | 2022 |
| Studying the interaction of germ cell tumors with the microenvironment reveals novel factors involved in cisplatin resistance MA Skowron, K Eul, A Stephan, GA Wakileh, GF Ludwig, C Söhngen, ... European Urology 81, S833-S834, 2022 | | 2022 |
| CD44v6-targeted CAR T-cell therapy for head and neck squamous cell carcinoma E Schulte, K Scheckenbach, A Bister, H Hanenberg, C Wiek, C Haist Laryngo-Rhino-Otologie 100 (S 02), 2021 | | 2021 |
